Stereotactic Surgery Devices Market Growth Report, 2033

The new report published by The Business Research Company, titled Stereotactic Surgery Devices Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the stereotactic surgery devices market size has grown steadily in recent years. It will grow from $21.43 billion in 2023 to $22.41 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The stereotactic surgery devices market size is expected to see steady growth in the next few years. It will grow to $27.21 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp

Stereotactic Surgical Devices Surge In Demand Amidst Rising Parkinson's Disease And Epilepsy Cases
The increasing number of Parkinson's disease and epilepsy are expected to boost the growth of the stereotactic surgical device market going forward. Parkinson's disease is a neurodegenerative illness that causes involuntary shaking, sluggish movement, and stiff, inflexible muscles, whereas epilepsy is a neurological ailment that affects the brain and renders patients more susceptible to experiencing recurring, unprovoked seizures. Stereotactic surgical devices are used to treat movement disorders, epilepsy, pain, and psychiatry, as well as Parkinson's disease. For instance, as per the study revealed by the Parkinson's Foundation, a New York-based national nonprofit organization, in 2022, in the United States, over 90,000 people will be diagnosed with Parkinson's disease each year. This is a 50% rise from the previously expected yearly rate of 60,000 diagnoses. Parkinson's disease (PD) affects almost a million people in the United States. By 2030, to increase to 1.2 million. Therefore, increasing cases of Parkinson's disease and epilepsy are driving the growth of the stereotactic surgical device market.

Elevating Stereotactic Surgical Device Market With Innovative Technologies
Technological advancements have emerged as the key trend gaining popularity in the stereotactic surgical device market. Major companies operating in the stereotactic surgical device market are developing innovative technologies to strengthen their position in the market. For instance, in May 2023, Brainlab, a Germany-based medical technology company has launched a new product called ExacTrac Dynamic Surface, which is a surface guided radiation therapy (SGRT) patient tracking and positioning system. The system offers high-speed thermal surface tracking technology combined with an update of ExacTrac X-ray monitoring, which increases versatility and accuracy in patient positioning and monitoring for various treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system emits a structured blue light pattern onto the patient surface that is acquired by two 3D cameras, and each surface point is augmented with a thermal signature, which is registered by the third in-unit camera.

The stereotactic surgery devices market covered in this report is segmented -

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10495&type=discount

Major companies operating in the stereotactic surgery devices market report are Alliance Oncology, Micromar Industria Commercio Ltda., Adeor Medical AG, Monteris Medical Holding AG, Inomed Medizintechnik GmbH, Ion Beam Applications S.A. (IBA), Elekta AB (publ), Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co. Ltd., Mitsubishi Heavy Industries Ltd., GE Healthcare, Siemens AG, Medtronic plc, Brainlab AG, Renishaw plc, Neuropace Inc., Microvention Inc., MR Solutions Ltd., RaySearch Laboratories AB, Alpha Omega Engineering Inc., FHC Inc., Nexstim Plc, Scopis GmbH, IZI Medical Products LLC, Integra LifeSciences Holdings Corporation, Computerized Imaging Reference Systems Inc., MRI Interventions Inc., ZAP Surgical Systems Inc., Schaerer Medical USA Inc.

Contents of the report:
1. Executive Summary
2. Stereotactic Surgery Devices Market Report Structure
3. Stereotactic Surgery Devices Market Trends And Strategies
4. Stereotactic Surgery Devices Market - Macro Economic Scenario
5. Stereotactic Surgery Devices Market Size And Growth
…..
27. Stereotactic Surgery Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.